Literature DB >> 16813605

Mutations in PHD-like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome.

C Badens1, C Lacoste, N Philip, N Martini, S Courrier, F Giuliano, A Verloes, A Munnich, B Leheup, L Burglen, S Odent, H Van Esch, N Levy.   

Abstract

Mutations in ATRX are associated with a wide and clinically heterogeneous spectrum of X-linked mental retardation syndromes. The ATRX protein, involved in chromatin remodelling, belongs to the family of SWI/SNF DNA helicases and contains a plant homeodomain (PHD)-like domain. To date, more than 60 different mutations have been reported in ATRX. One of them is recurrent and accounts for 20% of all the reported mutations, whereas all others are private. Most mutations are clustered in the two major functional domains, the helicase and the PHD-like domain. So far, no clear genotype-phenotype correlation has been established, with exception to the rare truncating mutations located at the C-terminal part of the protein, which are consistently associated with severe urogenital defects. In this study, we report the molecular analysis performed in 16 families positive for ATRX. Our findings indicate that, in addition to the previously described mutation 'hotspot' in the PHD-like domain, two other protein sections emerge as minor 'hotspots' in the helicase region encoded by exons 18-20 and 26-29, respectively, gathering 33% of all described mutations. Additionally, based on the clinical data collected for 22 patients from the 16 families, we observe that mutations in the PHD-like domain produce severe and permanent psychomotor deficiency, usually preventing patients from walking, as well as constant urogenital abnormalities, while mutations in the helicase domain lead to delayed but correct psychomotor acquisitions together with mild or absent urogenital abnormalities. In summary, mutations in the helicase domain are associated with milder phenotypes than mutations in the PHD-like domain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16813605     DOI: 10.1111/j.1399-0004.2006.00641.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  24 in total

1.  Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients.

Authors:  Julien Masliah-Planchon; Dominique Lévy; Delphine Héron; Fabienne Giuliano; Catherine Badens; Paul Fréneaux; Louise Galmiche; Jean-Marc Guinebretierre; Cécile Cellier; Joshua J Waterfall; Khadija Aït-Raïs; Gaëlle Pierron; Christophe Glorion; Isabelle Desguerre; Christine Soler; Anne Deville; Olivier Delattre; Jean Michon; Franck Bourdeaut
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

Review 2.  Mutant ATRX: uncovering a new therapeutic target for glioma.

Authors:  Santiago Haase; María Belén Garcia-Fabiani; Stephen Carney; David Altshuler; Felipe J Núñez; Flor M Méndez; Fernando Núñez; Pedro R Lowenstein; Maria G Castro
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

3.  A novel case of Greenberg dysplasia and genotype-phenotype correlation analysis for LBR pathogenic variants: An instructive example of one gene-multiple phenotypes.

Authors:  Elisa Giorgio; Fabio Sirchia; Martino Bosco; Nara Lygia M Sobreira; Enrico Grosso; Alessandro Brussino; Alfredo Brusco
Journal:  Am J Med Genet A       Date:  2018-12-18       Impact factor: 2.802

4.  The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9.

Authors:  Arunkumar Dhayalan; Raluca Tamas; Ina Bock; Anna Tattermusch; Emilia Dimitrova; Srikanth Kudithipudi; Sergey Ragozin; Albert Jeltsch
Journal:  Hum Mol Genet       Date:  2011-03-18       Impact factor: 6.150

Review 5.  One gene, many neuropsychiatric disorders: lessons from Mendelian diseases.

Authors:  Xiaolin Zhu; Anna C Need; Slavé Petrovski; David B Goldstein
Journal:  Nat Neurosci       Date:  2014-05-27       Impact factor: 24.884

6.  Exome Sequencing Discerns Syndromes in Patients from Consanguineous Families with Congenital Anomalies of the Kidneys and Urinary Tract.

Authors:  Asaf Vivante; Daw-Yang Hwang; Stefan Kohl; Jing Chen; Shirlee Shril; Julian Schulz; Amelie van der Ven; Ghaleb Daouk; Neveen A Soliman; Aravind Selvin Kumar; Prabha Senguttuvan; Elijah O Kehinde; Velibor Tasic; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2016-05-05       Impact factor: 10.121

7.  Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.

Authors:  Garilyn M Jentarra; Shannon L Olfers; Stephen G Rice; Nishit Srivastava; Gregg E Homanics; Mary Blue; Sakkubai Naidu; Vinodh Narayanan
Journal:  BMC Neurosci       Date:  2010-02-17       Impact factor: 3.288

8.  Neuroradiologic features in X-linked α-thalassemia/mental retardation syndrome.

Authors:  T Wada; H Ban; M Matsufuji; N Okamoto; K Enomoto; K Kurosawa; N Aida
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-16       Impact factor: 3.825

9.  Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.

Authors:  Lisa Mirabello; Bin Zhu; Roelof Koster; Eric Karlins; Michael Dean; Meredith Yeager; Matthew Gianferante; Logan G Spector; Lindsay M Morton; Danielle Karyadi; Leslie L Robison; Gregory T Armstrong; Smita Bhatia; Lei Song; Nathan Pankratz; Maisa Pinheiro; Julie M Gastier-Foster; Richard Gorlick; Silvia Regina Caminada de Toledo; Antonio S Petrilli; Ana Patino-Garcia; Fernando Lecanda; Miriam Gutierrez-Jimeno; Massimo Serra; Claudia Hattinger; Piero Picci; Katia Scotlandi; Adrienne M Flanagan; Roberto Tirabosco; Maria Fernanda Amary; Nilgün Kurucu; Inci Ergurhan Ilhan; Mandy L Ballinger; David M Thomas; Donald A Barkauskas; Gerardo Mejia-Baltodano; Patricia Valverde; Belynda D Hicks; Bin Zhu; Mingyi Wang; Amy A Hutchinson; Margaret Tucker; Joshua Sampson; Maria T Landi; Neal D Freedman; Susan Gapstur; Brian Carter; Robert N Hoover; Stephen J Chanock; Sharon A Savage
Journal:  JAMA Oncol       Date:  2020-05-01       Impact factor: 31.777

10.  Loss of ATRX in chondrocytes has minimal effects on skeletal development.

Authors:  Lauren A Solomon; Jennifer R Li; Nathalie G Bérubé; Frank Beier
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.